期刊文献+

卵巢浆液性癌的病理发病机制研究分析

Research of Ovarian Serous Carcinoma Pathology Pathogenesis
下载PDF
导出
摘要 目的本文主要是探讨和分析卵巢浆液性癌病理发病机制。方法选择2014年9月至2015年9月来我院接受治疗的20例卵巢浆液性癌患者临床资料作为研究对象,对其病理发病机制进行分析和探讨。结果经过对20例患者临床资料进行分析和比较之后不难发现,卵巢癌早期不具有较为明显的临床表现,缺乏可靠、有效的生物学标志物,患者确诊时一般都到中晚期,因为该种疾病化疗具有显著的耐药性,预后较差。结论卵巢浆液性癌患者要能尽早接受治疗,适龄女性一旦出现任何相关症状,要能够积极接受诊断,从根本上降低该种病症的病死率。 Objective This paper is to investigate and analyze the pathogenesis of ovarian serous carcinoma. Methods The clinical data of 20 cases of ovarian serous carcinoma treated in our hospital from September 2015 to September 2014 were studied. Results After analysis and comparison of the clinical data of 20 patients, it is not difficult to find that the early stage of ovarian cancer has no obvious clinical manifestations, and the lack of reliable and effective biological markers, and the patients are generally in the middle and late stage, because the disease chemotherapy has significant resistance, the prognosis is poor. Conclusion Patients with ovarian serous carcinoma should be treated as soon as possible, and any related symptoms should be able to actively accept the diagnosis and reduce the mortality of the disease.
作者 邹绍蕾
出处 《中国医药指南》 2016年第33期10-11,共2页 Guide of China Medicine
关键词 卵巢浆液性癌 病理发病机制 研究 Ovarian serous carcinoma Pathological mechanism Study
  • 引文网络
  • 相关文献

参考文献4

二级参考文献70

  • 1任凤岩,张淑兰,姜彦多,王丹波.卵巢子宫内膜样癌及其合并子宫内膜异位症的临床及病理分析[J].中国实用妇科与产科杂志,2007,23(9):708-709. 被引量:18
  • 2Shih IeM,Kunnan RJ.Ovarian tmnorigenesis: a proposed model based on morphological and molecular genetic analy- sis[J]. Am J Pathol,2004, 164 (5): 1511-1518.
  • 3Gilks CB,Prat J. Ovarian carcinoma pathology and genetics: recent advances[J]. Hum Pathol, 2009,40(9):1213-1223.
  • 4Singer G, Kurman RJ,Chang HW,et al. Diverse tumorigenic pathways in ovarian serous carcinoma[J]. Am J Pathol, 2002,160(4): 1223-1228.
  • 5Malpica A,Deavers MT,Lu K,et al. Grading ovarian serous carcinoma using a two-tier system[J]. Am J Surg Pathol, 2004,28(4):496-504.
  • 6O'Neill CJ,Deavers MT,Malpiea A,et al. An immunohis- tochemieal comparison between low-grade and high-grade ovarian serous carcinomas: significantly higher expression of p53, MIB1 , BCL2, ttER-2/neu, and C-KIT in high-grade neoplasms [J] Am J Surg Pathol,2005,29(8): 1034-1041.
  • 7Kurman RJ ,Shih IeM.The origin and pathogenesis of epi- thelial ovarian cancer: a proposed unifying theory[J]. Am J Surg Pathol, 2010,34(3):433-443.
  • 8Vang R,Shih IeM,Kurman RJ. Ovarian low-grade and high-grade serous carcinoma: pathogenesis,clinicopatho- logic and molecular biologic: features,and diagnostic prob- lems[J].Adv Anat Pathol, 2009,16(5):267-282.
  • 9Gershenson DM ,Sun CC,Lu KH, et al.Clinical behavior of stage II- IV low-grade serous eareinoma of the ovary[J]. Obstet Gynecol, 2006,108 (2) : 361-368.
  • 10Kurman R J, Shih IeM. The origin and pathogenesis of epithelial ovarian cancer:a proposed unifying theory[ J ]. Am Surg Pathol, 2010,34(3) :433-443.

共引文献14

相关主题

;
使用帮助 返回顶部